Form 4: Bausch Health CFO Receives RSU Award, Sells Shares

Bausch Health Companies Inc.'s EVP and CFO, Jean-Jacques Charhon, was granted 276,055 restricted share units and subsequently disposed of 35,977 shares to cover tax obligations.

Summary

• Jean-Jacques Charhon, EVP and CFO of Bausch Health Companies Inc. (BHC), was awarded 276,055 restricted share units (RSUs) on February 25, 2026.
• These RSUs will vest one-third on each of the first three anniversaries following the grant date, contingent on continued service.
• On February 26, 2026, Charhon disposed of 35,977 common shares at a price of $6.04 per share.
• This disposition was to satisfy tax withholding obligations upon the vesting of previously granted RSUs.
• Following these transactions, Charhon directly beneficially owns 755,538 common shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine executive compensation event. The RSU award is a positive for aligning management incentives, while the tax-related share sale is a standard practice and not indicative of negative sentiment.

Positives

• The award of 276,055 restricted share units (RSUs) to the EVP and CFO aligns management's interests with long-term shareholder value.
• The vesting schedule over three years encourages continued executive service and performance.

Negatives

• The disposition of 35,977 common shares, although for tax purposes, represents a reduction in direct beneficial ownership by the executive.

Risks

• No specific risks are detailed in this Form 4 filing beyond the general market risks associated with equity compensation.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the vesting schedule for the awarded restricted share units.

Industry Context

StockSavvy.ai notes that the grant of restricted share units (RSUs) is a standard practice in executive compensation across various industries, designed to incentivize long-term performance and align executive interests with shareholder returns. The subsequent sale of shares to cover tax obligations upon vesting is also a common and routine event for executives receiving equity compensation.

Stakeholder Impact

• Shareholders: The RSU award aligns executive incentives with long-term shareholder value. The tax-related share sale is a routine event and does not typically signal a change in company fundamentals.
• Employees: The compensation structure for a key executive may influence broader compensation strategies within the company.

Next Steps

• Vesting of the awarded restricted share units (RSUs) in one-third increments on the first three anniversaries of the grant date (February 25, 2026).

Key Dates

Keywords

Bausch Health, BHC, Form 4, Restricted Share Units, RSU, Insider Transaction, Executive Compensation, CFO, Jean-Jacques Charhon, Equity Award